Peritoneal Metastasis of Malignant Melanoma: A Case Report and Literature Review
This case report details a rare instance of peritoneal metastasis from malignant melanoma misdiagnosed as an ovarian tumor, highlighting the importance of accurate pathological diagnosis and the potential benefits of combined surgical, HIPEC, and targeted therapies for improving patient outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human body as a bustling, high-security city. Most cancers are like local gangs that cause trouble in one neighborhood, but malignant melanoma is a notorious, shape-shifting spy. It starts in the skin (the city's outer wall) but has a terrifying talent for slipping past security checkpoints, traveling through the bloodstream, and setting up secret bases in faraway districts like the lungs, bones, or the belly cavity. When this spy sets up shop in the peritoneum—the slippery, sack-like lining that wraps around your intestines and organs—it's a rare and dangerous event. Think of the peritoneum as the city's central park; if a spy hides there, it's hard to spot because the symptoms look exactly like a different kind of trouble, such as a garden overgrowth (ovarian cancer). Doctors rely on biopsies (taking a tiny sample to inspect under a microscope) and immunohistochemistry (using special chemical "flashlights" that make specific spy markers glow) to tell the difference between a local garden problem and an intruder. Understanding how to catch this elusive spy early is a matter of life and death, because once it spreads this far, the odds are usually stacked against the patient.
This paper tells the true story of a 45-year-old woman who walked into a hospital complaining of a bloated belly and a loss of appetite. At first, the medical team thought she had a primary ovarian tumor—a "local garden overgrowth"—because her scans showed a mass near her ovaries and fluid in her belly. They went in for surgery, and during the operation, a quick frozen test of the tissue suggested it was a "poorly differentiated carcinoma," a fancy way of saying it looked like a nasty, fast-growing cancer that didn't quite know what it was supposed to be. Based on this, the surgeons performed a major cleanup: removing the uterus, ovaries, and the fatty apron (omentum) covering the intestines, and even pumped heated chemotherapy directly into her belly to try to kill any lingering cancer cells.
However, the real twist came after the surgery when the pathologists took a closer look at the tissue under the microscope. The "chemical flashlights" (immunohistochemistry) revealed that the cells weren't ovarian at all; they were glowing positive for melanoma markers (S100, HMB45, MART-1) and negative for ovarian markers. The diagnosis was flipped: this wasn't a new ovarian cancer; it was metastatic melanoma that had traveled from a tiny, forgotten spot on her right buttock six years prior. It turns out she had a mole removed years ago that had a "malignant potential," but the cancer cells had gone into hiding and then reawakened, spreading to her lungs, bones, and the lining of her belly.
The paper details how the medical team then switched tactics. Since genetic testing showed the cancer had a specific "glitch" called a BRAF V600 mutation, they didn't use standard chemotherapy. Instead, they used a "dual-target" strategy: a pair of drugs (dabrafenib and trametinib) designed to specifically jam the engine of this mutated cancer. They also gave her a bone-strengthening drug (denosumab) because the cancer had also set up shop in her bones. The result? A year later, the patient is still alive, and her disease is stable—meaning the cancer isn't growing or spreading further.
The authors use this case to highlight a crucial lesson: when a patient has a belly full of mysterious nodules, doctors must dig deep into their past. Even if a patient had a skin mole removed years ago, it could be the source of a current crisis. The paper emphasizes that without a clear history of melanoma, this condition is easily misdiagnosed as ovarian cancer. By combining surgery, heated chemotherapy, and precise genetic-targeted drugs, the team managed to turn a situation that usually has a very poor outlook into one where the patient is doing well. The story serves as a reminder that in the complex city of the human body, knowing the history of the "spy" is just as important as seeing where it is hiding today.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.